Results 81 to 90 of about 23,747,035 (396)

Volume expansion enhances plasma endothelin-1 [PDF]

open access: yes, 2017
We hypothesized that acute volume expansion by saline infusion triggers the release of endothelin-1. Bolus intravenous saline infusion (8 mL/min) in six groups of conscious Wistar rats and spontaneously hypertensive rats did not change mean arterial ...
Abdel-Sayed, Saad   +2 more
core  

Endothelin and the ischaemic heart [PDF]

open access: yes, 2005
Soon after its identification as a powerful vasoconstrictor peptide, endothelin (ET-1) was implicated as a detrimental agent involved in determining the outcome of myocardial ischaemia and reperfusion.
Kane, K.A., McCabe, C., Wainwright, C.L.
core   +1 more source

The effect and mechanism of endothelin-1-induced intracellular free calcium in human lung adenocarcinoma cells SPC-A1

open access: yesChinese Journal of Lung Cancer, 2008
Background and objective Endothelin-1 (ET-1) is a potent mitogen involved in cell growth in human lung adenocarcinoma cells SPC-A1. The increase in intracellular free calcium ([Ca2+]i) plays a great role in this process.
Juan ZHOU   +3 more
doaj  

The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study

open access: yesEndocrine and Metabolic Science, 2023
Introduction: African Americans (AAs) have the highest prevalence of hypertension among United States racial/ethnic groups. Regulators of blood pressure, such as aldosterone and endothelin-1, impact glucose regulation.
Joshua J. Joseph   +7 more
doaj  

Arrhythmogenic action of endothelin-1 [PDF]

open access: yesCardiovascular Research, 2000
Dear Editor, It was highly interesting to read the ‘Letter to the Editor’ by Duru et al. [1] regarding the arrhythmogenic action of endothelin-1 (ET-1). ET-1 is supposed to act as a paracrine hormone released due to stretch or myocardial ischaemia in vivo. ET-1 prolonged action potential duration with early afterdepolarization (EAD) formation in right
Béla Merkely   +5 more
openaire   +3 more sources

Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT1) and endothelin‐1 type A receptor (ETAR), leading to autoantibody‐mediated ...
Wieke M. van Oostveen   +8 more
wiley   +1 more source

Murine study of portal hypertension associated endothelin-1 hypo-response [PDF]

open access: yes, 2015
AIM: To investigate endothelin-1 hypo-responsive associated with portal hypertension in order to improve patient treatment outcomes. METHODS: Wild type, eNOS(-/-) and iNOS(-/-) mice received partial portal vein ligation surgery to induce portal ...
Maluccio, Mary   +2 more
core   +1 more source

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato   +9 more
wiley   +1 more source

Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients [PDF]

open access: yes, 2018
• Background: The potent vasoconstrictor peptide endothelin-I has been shown to participate in the control of peripheral vascular tone and in the regulation of ocular perfusion.
Flammer, Josef   +5 more
core  

The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2012
Study objective: This study analyses for the first time endothelin-1 (ET-1) level, and gene polymorphisms for endothelin-1 (EDN1 gene) in patients with pulmonary arterial hypertension (PAH) in Egypt. Design: Cross-sectional study.
Emad Ibrahim   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy